Empasiprubart Biosimilar - Research Grade

Human

C2ï؟½

5mg/ml

IgG1 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P06681

Blue ice

Complement component C2 sits at the convergence of the classical and lectin pathways, governing C3 convertase assembly and downstream complement activation. Targeting C2, this research-grade anti-human recombinant monoclonal antibody is an unconjugated, non-therapeutic analog of empasiprubart provided for research use only (RUO). It is manufactured to stringent in vivo standards as an ultra-pure, low-endotoxin formulation and delivered in scalable milligram (mg) to gram (g) quantities to meet the demands of heavy-usage, high-throughput laboratories. The antibody suits complement-pathway neutralization and blocking assays, in vitro mechanistic studies, in vivo models of complement-mediated disease, and biologics characterization.

Complement C2

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks